Ankylosing Spondylitis
Understanding Ankylosing Spondylitis (AS), also known as Bechterews Disease or Marie-Strumpell Disease, requires accurate clinical documentation and medical coding. This resource provides information on AS diagnosis, including ICD-10 codes, symptoms, treatment, and healthcare management. Learn about the diagnostic criteria for Ankylosing Spondylitis and best practices for documenting this condition in medical records. Find resources for healthcare professionals, including coding guidelines for AS and information on related conditions.
Chronic inflammatory arthritis primarily affecting the spine and sacroiliac joints, causing stiffness and pain.
Lower back pain, stiffness, fatigue, limited spinal mobility, uveitis, peripheral joint involvement.
Rheumatology clinics, physical therapy, pain management centers, primary care offices.
ICD-10 Code Families
Complete code families applicable to M45.9
When to use each related code
| Description | When to use |
|---|---|
| Inflammatory arthritis affecting the spine. | Use for chronic back pain with spinal fusion, HLA-B27 positive. Consider AS subtypes. |
| Psoriatic arthritis with spinal involvement. | Use when psoriatic skin lesions and inflammatory spinal pain coincide. Check for nail changes, dactylitis. |
| Reactive arthritis following infection. | Use for acute arthritis after GI or GU infection. Look for conjunctivitis, urethritis. |
Best-practice checklist
- ✓Document axial spondyloarthritis features.
- ✓Note sacroiliitis evidence via imaging.
- ✓HLA-B27 status, if tested, for AS.
- ✓Specify affected joints/spinal areas.
- ✓Record inflammatory back pain details.
Common pitfalls to avoid
Coding AS without specifying active disease, location, or manifestations leads to inaccurate severity and reimbursement.
Incorrectly coding HLA-B27 testing related to AS diagnosis can impact medical necessity reviews and denials.
Overlapping symptoms with related conditions like osteoarthritis or rheumatoid arthritis can lead to misdiagnosis and incorrect coding.
Best-practice tips
- 01Code ICD-10 M45.Ankylosing spondylitis for accurate claims.
- 02Document disease activity using BASDAI, ASDAS for improved CDI.
- 03Ensure compliance with payer guidelines for AS treatment authorization.
- 04Regularly assess spinal mobility, function for optimal patient care.
- 05Patient education on exercise, posture for symptom management.
Step-by-step checklist
- 1
Confirm inflammatory back pain onset <45 years old (ICD-10 M45.8)
- 2
Assess HLA-B27 status (ICD-10 Z98.890) and document result
- 3
Verify sacroiliitis via imaging (ICD-10 M46.1) - X-ray/MRI
- 4
Evaluate for AS-related extra-articular features (e.g., uveitis, IBD)
Ready-to-paste narrative
Patient presents with complaints consistent with ankylosing spondylitis (AS), also known as Bechterew's disease or Marie-Strumpell disease. The patient reports chronic back pain, stiffness, and limited spinal mobility, particularly in the morning or after periods of inactivity. Symptoms include inflammatory back pain, sacroiliitis, and enthesitis. Onset of symptoms was gradual and began approximately [duration] ago. The patient's age of onset is [age] which is consistent with the typical demographics for AS. Physical examination reveals reduced range of motion in the lumbar spine, tenderness to palpation in the sacroiliac joints, and potential signs of peripheral arthritis. Imaging studies, including sacroiliac joint X-rays and potentially MRI or CT scans, will be ordered to assess for sacroiliitis and other characteristic changes consistent with ankylosing spondylitis. Differential diagnosis includes other spondyloarthropathies, such as psoriatic arthritis and reactive arthritis, as well as degenerative disc disease and osteoarthritis. Initial treatment plan includes NSAIDs for pain management and inflammation control, physical therapy for mobility and strengthening, and patient education regarding disease management. Referral to rheumatology for further evaluation and consideration of disease-modifying antirheumatic drugs (DMARDs), such as TNF inhibitors, may be necessary if symptoms persist or worsen. Patient will be monitored for disease progression, including extra-articular manifestations such as uveitis and cardiovascular involvement. ICD-10 code M45. Ankylosing spondylitis will be used for diagnostic coding and medical billing purposes. Continued follow-up care will focus on symptom management, functional improvement, and preventing long-term complications of ankylosing spondylitis.
Common questions and answers
What are the key differentiating diagnostic features between Ankylosing Spondylitis (AS) and mechanical back pain in clinical practice?+
Differentiating Ankylosing Spondylitis (AS) from mechanical back pain requires careful consideration of several factors. While both present with back pain, AS typically exhibits inflammatory characteristics such as morning stiffness lasting more than 30 minutes, improvement with exercise but not rest, and nighttime pain that alternates sides. Furthermore, patients with AS often report insidious onset before age 45 and experience pain in the sacroiliac joints. Physical exam findings may reveal reduced spinal mobility and tenderness over the sacroiliac joints. Imaging plays a crucial role, with radiographs and MRI of the sacroiliac joints being key for identifying characteristic AS changes like sacroiliitis. Explore how a comprehensive approach combining symptom evaluation, physical exam, and imaging can enhance diagnostic accuracy in differentiating AS from mechanical back pain. Consider implementing standardized assessment tools for inflammatory back pain to aid early diagnosis of AS and improve patient outcomes. Learn more about the specific imaging findings that differentiate AS from other forms of back pain.
How can clinicians effectively use imaging studies like MRI and X-ray to confirm a suspected Ankylosing Spondylitis (AS), Bechterews Disease, or Marie-Strumpell Disease diagnosis and differentiate it from other spondyloarthropathies?+
Imaging studies play a vital role in confirming a suspected diagnosis of Ankylosing Spondylitis (AS), also known as Bechterew's Disease or Marie-Strümpell Disease, and distinguishing it from other spondyloarthropathies. Radiographic evidence of sacroiliitis, specifically blurring, erosions, or sclerosis of the sacroiliac joints, is a hallmark of AS. MRI can detect early inflammatory changes in the sacroiliac joints and spine, often before they are visible on X-ray, making it particularly useful in early-stage AS. While both MRI and X-ray are valuable tools, MRI offers increased sensitivity for detecting active inflammation. To differentiate AS from other spondyloarthropathies, clinicians should consider the distribution of affected joints, the presence of extra-articular manifestations (e.g., uveitis, inflammatory bowel disease), and genetic markers like HLA-B27. Explore how combining clinical findings with imaging features can enhance diagnostic specificity. Learn more about the assessment of MRI and X-ray findings in AS by considering the ASAS classification criteria for axial spondyloarthritis.
What are the best practices for managing Ankylosing Spondylitis (AS) long-term, including pharmacological and non-pharmacological treatment strategies, in adults and children?+
Long-term management of Ankylosing Spondylitis (AS) requires a multifaceted approach involving both pharmacological and non-pharmacological strategies tailored to the individual patient, whether adult or child. Non-pharmacological interventions include regular exercise focusing on posture, range of motion, and spinal mobility; physical therapy; patient education; and smoking cessation. Pharmacological treatment typically begins with nonsteroidal anti-inflammatory drugs (NSAIDs) to control pain and inflammation. For patients with persistent active disease, biologic agents, such as tumor necrosis factor (TNF) inhibitors, may be considered. In children with AS, treatment decisions should be made in consultation with a pediatric rheumatologist, carefully balancing the benefits and risks of medications. Consider implementing a comprehensive care plan that incorporates regular monitoring of disease activity, functional capacity, and patient-reported outcomes. Explore how incorporating self-management techniques can empower patients to actively participate in their care. Learn more about current guidelines for managing AS, including specific recommendations for medication selection and monitoring, to ensure optimal patient care throughout the course of the disease.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.